What happens with HRT (especially estrogen)?
β’ Estrogen increases hepatic VLDL synthesis β which increases serum triglycerides.
β’ Especially with oral estrogen, the first-pass effect in the liverstrongly stimulates triglyceride production.
β’ This can exacerbate pre-existing hypertriglyceridemia.
Why is this dangerous?
Marked hypertriglyceridemia (typically >500β1000 mg/dL) can trigger:
β’ Acute pancreatitis
β’ Increased risk of thromboembolic events (estrogen already increases coagulation factors).
So giving HRT in someone with high triglycerides could tip them into pancreatitis or vascular complications.
Summary Table:
| Effect of Estrogen | Outcome | 
|---|---|
| β Hepatic VLDL synthesis | β Triglycerides | 
| β Triglycerides in predisposed patients | Risk of pancreatitis | 
| β Coagulation factors | Thrombosis risk | 
Clinical Tip:
β’ If estrogen is absolutely needed, transdermal estrogen(patch/gel) may be safer as it bypasses the liver, so less effect on triglycerides.
β’ But in severe hypertriglyceridemia, estrogen is avoided altogether.